ibi110
innovent biologics
['ibi110', 'innovent biologics', 'innovent', 'innovent_2011', 'innovent bio']
innovent presents clinical data of ibi110 (anti-lag-3 monoclonal antibody) at the 2022 american society of clinical oncology (asco) annual meeting 
To develop and commercialize high-quality biopharmaceuticals that are affordable to ordinary people.